The Pain Management Devices And Therapies Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Pain Management Devices And Therapies Market:
https://www.thebusinessresearchcompany.com/report/pain-management-devices-and-therapies-global-market-report
According to The Business Research Company’s Pain Management Devices And
Therapies Global Market Report 2024, The pain management devices and therapies
market size has grown rapidly in recent years. It will grow from $4.38 billion
in 2023 to $4.83 billion in 2024 at a compound annual growth rate (CAGR) of
10.3%. The growth in the historic period can be
attributed to increasing prevalence of chronic pain, growing demand for minimally
invasive pain management procedures, increasing demand for personalized pain
management, growing geriatric population, increasing awareness of pain
management options.
The pain management devices and therapies market size is expected to see
rapidly grown in the next few years. It will grow to $6.49 billion in 2028 at a
compound annual growth rate (CAGR) of 7.6%.
The growth in the forecast period can be attributed to non-opioid
alternatives, remote and digital health, rising opioid epidemic, growing
popularity of integrative pain management, value-based care. Major trends in the
forecast period include advances in pain management technology, neuromodulation
devices, digital therapeutics, wearable pain management devices, regenerative
therapies.
An increase in demand for pain management devices due rise in chronic diseases
is driving the growth of the pain management devices and therapies market.
Chronic diseases such as cancer, heart stroke often lead to unbearable pain in
patients and thus creating a demand for pain management drugs and therapies.
Chronic diseases persist over a long period and deteriorate the health of the
patient. As reported in an article by the Brazilian Journal of Nephrology,
around 60% of patients with chronic kidney disease reported pain of any kind of
intensity, which required pain management drugs. Similarly, according to a
report in the 'US National Library of Medicine, approximately 45% or 133
million of all Americans suffered from at least one chronic disease. It is also
stated that more than two-thirds of all deaths are due to one of the chronic
illnesses, which included coronary heart sickness, cancer, stroke, persistent
obstructive pulmonary disease, and diabetes. This rise in chronic diseases is
increasing the demand for pain management devices and therapies and driving the
pain management devices and therapies market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=2490&type=smp
The pain management devices and therapies market covered in this report is
segmented –
1) By Type: Electrical Stimulators, Ablation Devices, Neurostimulators,
Analgesic Pumps
2) By Neurostimulation Devices: Spinal Cord Stimulation (SCS) Devices, Deep
Brain Stimulation Devices, Vagus Nerve Stimulation Devices, Sacral Nerve
Stimulation Devices
3) By Electrical Stimulation Devices: Transcutaneous Electrical Nerve
Stimulation (TENS) Devices, Neuromuscular Electrical Stimulation (NMES/EMS)
Devices, Combination Devices, Electrotherapy Devices, TNS
4) By Ablation Devices: Radiofrequency Ablation Devices, Cryoablation Devices
5) By Analgesic Infusion Pumps: Intrathecal Infusion Pumps, External Infusion
Pumps
6) By Application: Neuropathic Pain, Cancer Pain, Facial & Migraine Pain,
Musculoskeletal Pain, Trauma
Companies in the parathyroid hormone market are focusing on developing
biosimilars of parathyroid-based drugs. A biosimilar is a biological product
that is developed to be similar to an already FDA-approved biologic, known as
the reference product. Biosimilars potentially offer consumers the opportunity
to reduce their healthcare costs without compromising on treatment standards,
which is why parathyroid hormone manufacturing companies are investing in them.
For instance, in January 2021, Theramex a UK-based pharmaceutical company
launched Livogiva. Teriparatide, the only bone anabolic medication for
osteoporosis, is now available in a novel form called Livogiva, a pre-filled
pen that makes it simple for patients who are at high risk of osteoporosis to
take. Livogiva is recommended for postmenopausal women with osteoporosis who
are at higher risk of fracture .
The pain management devices and therapies market report table of contents
includes:
1. Executive Summary
2. Pain
Management Devices And Therapies Market Characteristics
3. Pain
Management Devices And Therapies Market Trends And Strategies
4. Pain
Management Devices And Therapies Market - Macro Economic Scenario
5. Global
Pain Management Devices And Therapies Market Size and Growth
.
31. Global Pain Management Devices And Therapies Market Competitive
Benchmarking
32. Global
Pain Management Devices And Therapies Market Competitive Dashboard
33. Key
Mergers And Acquisitions In The Pain Management Devices And Therapies Market
34. Pain
Management Devices And Therapies Market Future Outlook and Potential Analysis
35.
Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model:
https://www.thebusinessresearchcompany.com/global-market-model
No comments:
Post a Comment